Allergen immunotherapy inhibits airway eosinophilia, hyperresponsiveness and IL-4 production in a murine model of allergic asthma.

被引：0
|
作者：
Van Oosterhout, AJM
Van Esch, B
Hofman, G
Nijkamp, FP
Kapsenberg, ML
Savelkoul, HFJ
Weller, FR
机构：
[1] Univ Utrecht, Dept Pharmacol & Pathophysiol, NL-3508 TB Utrecht, Netherlands
[2] Lab Cellbiol & Histol, Amsterdam, Netherlands
[3] Dept Immunol, Rotterdam, Netherlands
[4] Dept Pulm, Amsterdam, Netherlands
来源：
FASEB JOURNAL | 1998年 / 12卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
3440
引用
收藏
页码：A592 / A592
页数：1
相关论文
共 50 条
  • [1] Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma
    Van Oosterhout, AJM
    Van Esch, B
    Hofman, G
    Hofstra, CL
    Van Ark, I
    Nijkamp, FP
    Kapsenberg, ML
    Savelkoul, HFJ
    Weller, FR
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (04) : 622 - 628
  • [2] IL16 inhibits airway hyperresponsiveness and eosinophilia in a murine model for allergic asthma.
    De Bie, JJ
    Henricks, PAJ
    Jonker, EH
    Cruikshank, WW
    Nijkamp, FP
    Van Oosterhout, AJM
    [J]. FASEB JOURNAL, 1998, 12 (05): : A925 - A925
  • [3] Opposite effect of protein and peptide immunotherapy on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma.
    Janssen, EM
    Wauben, MHM
    Jonker, EH
    Hofman, G
    Van Eden, W
    Nijkamp, FP
    Van Oosterhout, AJM
    [J]. FASEB JOURNAL, 1998, 12 (04): : A592 - A592
  • [4] Continuing IL-4 production is required for pulmonary eosinophilia and mucus production, but not airway hyperresponsiveness (AHR), in a mouse model of asthma.
    Zhao, Y
    Walter, AM
    Morris, SC
    Finkelman, FD
    [J]. FASEB JOURNAL, 2000, 14 (06): : A1068 - A1068
  • [5] 5-hydroxytryptamine and histamine are involved in airway hyperresponsiveness and eosinophilia in a murine model of allergic asthma.
    De Bie, JJ
    Henricks, PAJ
    Jonker, EH
    Hofman, GA
    Muis, T
    Nijkamp, FP
    Van Oosterhout, AJM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U43 - U43
  • [6] A murine IL-4 antagonist mutant protein inhibits airway hyperresponsiveness (AHR) and airway eosinophilia in mice
    Tomkinson, A
    Cieslewicz, G
    Duez, C
    Shanafelt, MC
    Gundel, R
    Gelfand, EW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A20 - A20
  • [7] Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma
    VanOosterhout, AJM
    Hofstra, CL
    Shields, R
    Chan, B
    VanArk, I
    Jardieu, PM
    Nijkamp, FP
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (03) : 386 - 392
  • [8] Effects of IL-4 receptor a blockade during allergen-specific immunotherapy in a murine model of allergic asthma
    Heine, S.
    Russkamp, D.
    Aguilar-Pimentel, A.
    Alessandrini, F.
    Gailus-Durner, V
    Fuchs, H.
    Ohnmacht, C.
    De Angelis, Hrabe M.
    Ollert, M.
    Schmidt-Weber, C.
    Blank, S.
    [J]. ALLERGY, 2019, 74 : 197 - 198
  • [9] Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma
    Wilder, JA
    Collie, DDS
    Wilson, BS
    Bice, DE
    Lyons, CR
    Lipscomb, MF
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (06) : 1326 - 1334
  • [10] Role for IL-10 in allergen immunotherapy in a mouse model of allergic asthma.
    van Esch, BCAM
    Vissers, JLM
    Nijkamp, FP
    Kapsenberg, ML
    Weller, FR
    van Oosterhout, AJM
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R166 - R166
12345